Skip to main navigation Skip to search Skip to main content

AbbVie Leuprolide - A Phase 3, Multicenter, Open-Label, Two-Part Study to Evaluate the Safety, Efficacy, Pharmacokinetics, and Pharmacodynamics of Leuprolide Acetate 45mg 6-Month Depot Formulation in Children with Central

Project: Research

Project Details

StatusFinished
Effective start/end date10/22/18 → 10/22/23

Funding

  • AbbVie Incorporated: $24,094.76